Diffuse Large B-Cell Lymphomas and Burkitt Lymphoma

Fernandez de Sevilla, 1998, Diffuse large B-cell lymphoma: is morphologic subdivision useful in clinical management?, Eur J Haematol, 60, 202 Diebold, 2002, Diffuse large B-cell lymphoma: a clinicopathologic analysis of 444 cases classified according to the updated Kiel classification, Leuk Lymphoma, 43, 97, 10.1080/10428190210173 Cabanillas, 1992, Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma, Blood, 79, 1024, 10.1182/blood.V79.4.1024.bloodjournal7941024 Kremer, 2003, Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders, Lab Invest, 83, 107, 10.1097/01.LAB.0000050762.61660.27 Davis, 1999, Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression, Clin Cancer Res, 5, 611 Yamaguchi, 2002, De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients, Blood, 99, 815, 10.1182/blood.V99.3.815 Ennishi, 2008, CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy, Ann Oncol, 19, 1921, 10.1093/annonc/mdn392 Kuppers, 1999, Cellular origin of human B-cell lymphomas, N Engl J Med, 341, 1520, 10.1056/NEJM199911113412007 Bea, 2004, Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas, J Clin Oncol, 22, 3498, 10.1200/JCO.2004.11.025 Chaganti, 2000, Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance, Semin Hematol, 37, 396, 10.1016/S0037-1963(00)90019-2 Pasqualucci, 2001, Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas, Nature, 412, 341, 10.1038/35085588 Dent, 2002, Regulation of gene expression by the proto-oncogene BCL-6, Crit Rev Oncol Hematol, 41, 1, 10.1016/S1040-8428(01)00164-0 Phan, 2004, The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells, Nature, 432, 635, 10.1038/nature03147 Bastard, 1994, LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients, Blood, 83, 2423, 10.1182/blood.V83.9.2423.2423 Barrans, 2002, Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma, Br J Haematol, 117, 322, 10.1046/j.1365-2141.2002.03435.x Hermine, 1996, Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA), Blood, 87, 265, 10.1182/blood.V87.1.265.265 Gascoyne, 1997, Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma, Blood, 90, 244, 10.1182/blood.V90.1.244 Pasqualucci, 2003, Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma, Blood, 101, 2914, 10.1182/blood-2002-11-3387 Young, 2008, Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study, Blood, 112, 3088, 10.1182/blood-2008-01-129783 Houldsworth, 2004, Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas, Blood, 103, 1862, 10.1182/blood-2003-04-1359 Alizadeh, 2000, Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, Nature, 403, 503, 10.1038/35000501 Rosenwald, 2002, The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma, N Engl J Med, 346, 1937, 10.1056/NEJMoa012914 Lenz, 2008, Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways, Proc Natl Acad Sci U S A, 105, 13520, 10.1073/pnas.0804295105 Lossos, 2000, Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas, Proc Natl Acad Sci U S A, 97, 10209, 10.1073/pnas.180316097 Iqbal, 2007, Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma, Leukemia, 21, 2332, 10.1038/sj.leu.2404856 Ngo, 2006, A loss-of-function RNA interference screen for molecular targets in cancer, Nature, 441, 106, 10.1038/nature04687 Lenz, 2008, Stromal gene signatures in large-B-cell lymphomas, N Engl J Med, 359, 2313, 10.1056/NEJMoa0802885 Lossos, 2004, Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes, N Engl J Med, 350, 1828, 10.1056/NEJMoa032520 Rimsza, 2008, Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP, Blood, 112, 3425, 10.1182/blood-2008-02-137372 Hans, 2004, Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray, Blood, 103, 275, 10.1182/blood-2003-05-1545 de Jong, 2007, Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications–a study from the Lunenburg Lymphoma Biomarker Consortium, J Clin Oncol, 25, 805, 10.1200/JCO.2006.09.4490 Barrans, 2002, Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma, Blood, 99, 1136, 10.1182/blood.V99.4.1136 Chang, 2004, Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma, Am J Surg Pathol, 28, 464, 10.1097/00000478-200404000-00005 Colomo, 2003, Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma, Blood, 101, 78, 10.1182/blood-2002-04-1286 De Paepe, 2005, Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas, J Clin Oncol, 23, 7060, 10.1200/JCO.2005.15.503 Nyman, 2007, Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy, Blood, 109, 4930, 10.1182/blood-2006-09-047068 de Leval, 2003, Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance, Histopathology, 43, 509, 10.1111/j.1365-2559.2003.01758.x Lossos, 2006, Prognostic biomarkers in diffuse large B-cell lymphoma, J Clin Oncol, 24, 995, 10.1200/JCO.2005.02.4786 Shipp, 2002, Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning, Nat Med, 8, 68, 10.1038/nm0102-68 Banham, 2005, Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma, Clin Cancer Res, 11, 1065, 10.1158/1078-0432.1065.11.3 Natkunam, 2008, LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab, J Clin Oncol, 26, 447, 10.1200/JCO.2007.13.0690 Coiffier, 2007, Rituximab therapy in malignant lymphoma, Oncogene, 26, 3603, 10.1038/sj.onc.1210376 Dogan, 2003, Micronodular T-cell/histiocyte-rich large B-cell lymphoma of the spleen: histology, immunophenotype, and differential diagnosis, Am J Surg Pathol, 27, 903, 10.1097/00000478-200307000-00005 Lim, 2002, T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells, Am J Surg Pathol, 26, 1458, 10.1097/00000478-200211000-00008 Achten, 2002, Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features, Histopathology, 40, 31, 10.1046/j.1365-2559.2002.01291.x Rudiger, 1998, Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry, Am J Surg Pathol, 22, 1184, 10.1097/00000478-199810000-00003 Nam-Cha, 2008, PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma, Am J Surg Pathol, 32, 1252, 10.1097/PAS.0b013e318165b0d6 Monti, 2005, Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response, Blood, 105, 1851, 10.1182/blood-2004-07-2947 Rudiger, 2002, Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma, Ann Oncol, 13, 44, 10.1093/annonc/13.S1.44 Franke, 2002, Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin's lymphoma, Am J Pathol, 161, 1861, 10.1016/S0002-9440(10)64462-8 Maes, 2001, Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features, Ann Oncol, 12, 853, 10.1023/A:1011195708834 Bouabdallah, 2003, T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis, J Clin Oncol, 21, 1271, 10.1200/JCO.2003.06.046 Batchelor, 2006, Primary CNS lymphoma, J Clin Oncol, 24, 1281, 10.1200/JCO.2005.04.8819 Braaten, 2003, BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma, Clin Cancer Res, 9, 1063 Camilleri-Broet, 2006, A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases, Blood, 107, 190, 10.1182/blood-2005-03-1024 Montesinos-Rongen, 2009, Primary lymphoma of the central nervous system: just DLBCL or not?, Blood, 113, 7, 10.1182/blood-2008-04-149005 Cady, 2008, Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course, J Clin Oncol, 26, 4814, 10.1200/JCO.2008.16.1455 Rubenstein, 2006, Gene expression and angiotropism in primary CNS lymphoma, Blood, 107, 3716, 10.1182/blood-2005-03-0897 Montesinos-Rongen, 2008, Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell, Leukemia, 22, 400, 10.1038/sj.leu.2405019 Tun, 2008, Pathway analysis of primary central nervous system lymphoma, Blood, 111, 3200, 10.1182/blood-2007-10-119099 Dijkman, 2006, Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID, Blood, 107, 4926, 10.1182/blood-2005-08-3443 Hoefnagel, 2005, Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling, Blood, 105, 3671, 10.1182/blood-2004-04-1594 Oyama, 2003, Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients, Am J Surg Pathol, 27, 16, 10.1097/00000478-200301000-00003 Oyama, 2007, Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients, Clin Cancer Res, 13, 5124, 10.1158/1078-0432.CCR-06-2823 Shimoyama, 2006, Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review, J Clin Exp Hematop, 46, 1, 10.3960/jslrt.46.1 Park, 2007, The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma, Blood, 110, 972, 10.1182/blood-2007-01-067769 Addis, 1986, Large cell lymphoma of the mediastinum: a B-cell tumour of probable thymic origin, Histopathology, 10, 379, 10.1111/j.1365-2559.1986.tb02491.x Isaacson, 1987, The human thymus contains a novel population of B-lymphocytes, Lancet, ii, 1488, 10.1016/S0140-6736(87)92622-5 Jacobson, 1988, Mediastinal large cell lymphoma: an uncommon subset of adult lymphoma curable with combined modality therapy, Cancer, 62, 1893, 10.1002/1097-0142(19881101)62:9<1893::AID-CNCR2820620904>3.0.CO;2-X Cazals-Hatem, 1996, Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (“Groupe d'Etude des Lymphomes de l'Adulte”) study, Am J Surg Pathol, 20, 877, 10.1097/00000478-199607000-00012 Zinzani, 2001, Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy, Haematologica, 86, 187 Rosenwald, 2003, Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma, J Exp Med, 198, 851, 10.1084/jem.20031074 Lamarre, 1989, Primary large cell lymphoma of the mediastinum. A histologic and immunophenotypic study of 29 cases, Am J Surg Pathol, 13, 730, 10.1097/00000478-198909000-00002 Pileri, 2003, Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins, Am J Pathol, 162, 243, 10.1016/S0002-9440(10)63815-1 de Leval, 2001, Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells?, Am J Surg Pathol, 25, 1277, 10.1097/00000478-200110000-00008 Calaminici, 2004, CD23 expression in mediastinal large B-cell lymphomas, Histopathology, 45, 619, 10.1111/j.1365-2559.2004.01969.x Copie-Bergman, 2002, MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas, Mod Pathol, 15, 1172, 10.1097/01.MP.0000032534.81894.B3 Copie-Bergman, 2003, Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma, Blood, 101, 2756, 10.1182/blood-2002-07-2215 Savage, 2003, The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin's lymphoma, Blood, 102, 3871, 10.1182/blood-2003-06-1841 Rodig, 2007, Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma, Am J Surg Pathol, 31, 106, 10.1097/01.pas.0000213334.40358.0e Leithauser, 2001, Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma, Blood, 98, 2762, 10.1182/blood.V98.9.2762 Tsang, 1996, Molecular characterization of primary mediastinal B cell lymphoma, Am J Pathol, 148, 2017 Joos, 1996, Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene, Blood, 87, 1571, 10.1182/blood.V87.4.1571.bloodjournal8741571 Wessendorf, 2007, Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH), Leukemia, 21, 2463, 10.1038/sj.leu.2404919 Joos, 2003, Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2, Int J Cancer, 103, 489, 10.1002/ijc.10845 Feuerhake, 2005, NF{kappa}B activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes, Blood, 106, 1392, 10.1182/blood-2004-12-4901 Guiter, 2004, Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma, Blood, 104, 543, 10.1182/blood-2003-10-3545 Melzner, 2005, Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line, Blood, 105, 2535, 10.1182/blood-2004-09-3701 Weniger, 2006, Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation, Oncogene, 25, 2679, 10.1038/sj.onc.1209151 Renne, 2007, High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma, Leukemia, 21, 780, 10.1038/sj.leu.2404594 Rudiger, 1998, Workshop report on Hodgkin's disease and related diseases (‘grey zone’ lymphoma), Ann Oncol, 9, S31, 10.1023/A:1008466208072 Traverse-Glehen, 2005, Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma, Am J Surg Pathol, 29, 1411, 10.1097/01.pas.0000180856.74572.73 Calvo, 2004, Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma, Adv Anat Pathol, 11, 227, 10.1097/01.pap.0000138144.11635.f8 Murase, 2000, An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome, Br J Haematol, 111, 826, 10.1046/j.1365-2141.2000.02426.x Ferreri, 2008, The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B-cell lymphoma, Br J Haematol, 143, 253, 10.1111/j.1365-2141.2008.07338.x Khalidi, 1998, Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases, Mod Pathol, 11, 983 Ponzoni, 2007, Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting, J Clin Oncol, 25, 3168, 10.1200/JCO.2006.08.2313 Ferreri, 2004, Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’, Br J Haematol, 127, 173, 10.1111/j.1365-2141.2004.05177.x Yegappan, 2001, Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma, Mod Pathol, 14, 1147, 10.1038/modpathol.3880450 Ponzoni, 2000, Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis, Hum Pathol, 31, 220, 10.1016/S0046-8177(00)80223-3 Nakatsuka, 2002, Pyothorax-associated lymphoma: a review of 106 cases, J Clin Oncol, 20, 4255, 10.1200/JCO.2002.09.021 Petitjean, 2002, Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B-and T-cell phenotype, Am J Surg Pathol, 26, 724, 10.1097/00000478-200206000-00005 Kanno, 1998, Mechanism for the development of pyothorax-associated lymphoma, Pathol Int, 48, 653, 10.1111/j.1440-1827.1998.tb03966.x Yamato, 2001, Evidence for local immunosuppression and demonstration of c-myc amplification in pyothorax-associated lymphoma, Histopathology, 39, 163, 10.1046/j.1365-2559.2001.01197.x Nishiu, 2004, Distinct pattern of gene expression in pyothorax-associated lymphoma (PAL), a lymphoma developing in long-standing inflammation, Cancer Sci, 95, 828, 10.1111/j.1349-7006.2004.tb02189.x Takakuwa, 2008, Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein-Barr virus infection, Leukemia, 22, 620, 10.1038/sj.leu.2405059 Copie-Bergman, 1997, Epstein-Barr virus in B-cell lymphomas associated with chronic suppurative inflammation, J Pathol, 183, 287, 10.1002/(SICI)1096-9896(199711)183:3<287::AID-PATH932>3.0.CO;2-Q Cheuk, 2005, Metallic implant-associated lymphoma: a distinct subgroup of large B-cell lymphoma related to pyothorax-associated lymphoma?, Am J Surg Pathol, 29, 832, 10.1097/01.pas.0000157747.10967.f4 Guinee, 1994, Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis, Am J Surg Pathol, 18, 753, 10.1097/00000478-199408000-00001 Beaty, 2001, Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features, Am J Surg Pathol, 25, 1111, 10.1097/00000478-200109000-00001 Saxena, 2002, Posttransplant diffuse large B-cell lymphoma of “lymphomatoid granulomatosis” type, Virchows Arch, 441, 622, 10.1007/s00428-002-0694-x Myers, 1995, Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection, Am J Surg Pathol, 19, 1300, 10.1097/00000478-199511000-00011 Delecluse, 1997, Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection, Blood, 89, 1413, 10.1182/blood.V89.4.1413 Colomo, 2004, Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities, Am J Surg Pathol, 28, 736, 10.1097/01.pas.0000126781.87158.e3 Teruya-Feldstein, 2004, CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogeneous spectrum in both HIV-positive and -negative patients, Ann Oncol, 15, 1673, 10.1093/annonc/mdh399 Dong, 2005, Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr Virus-associated extramedullary plasmacytic neoplasm, Am J Surg Pathol, 29, 1633, 10.1097/01.pas.0000173023.02724.1f Chadburn, 2004, KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma, Am J Surg Pathol, 28, 1401, 10.1097/01.pas.0000138177.10829.5c Vega, 2005, Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles, Mod Pathol, 18, 806, 10.1038/modpathol.3800355 Delsol, 1997, A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation, Blood, 89, 1483, 10.1182/blood.V89.5.1483 Gascoyne, 2003, ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases, Blood, 102, 2568, 10.1182/blood-2003-03-0786 Onciu, 2003, ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases, Blood, 102, 2642, 10.1182/blood-2003-04-1095 Cesarman, 1995, Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas, N Engl J Med, 332, 1186, 10.1056/NEJM199505043321802 Horenstein, 1997, Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8, Blood, 90, 1186, 10.1182/blood.V90.3.1186 Gaidano, 1997, Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen, Blood, 90, 4894 Jenner, 2003, Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile, Proc Natl Acad Sci U S A, 100, 10399, 10.1073/pnas.1630810100 Klein, 2003, Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts, Blood, 101, 4115, 10.1182/blood-2002-10-3090 Boulanger, 2005, Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS, J Clin Oncol, 23, 4372, 10.1200/JCO.2005.07.084 Oksenhendler, 2002, High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease, Blood, 99, 2331, 10.1182/blood.V99.7.2331 Dupin, 2000, HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma, Blood, 95, 1406, 10.1182/blood.V95.4.1406.004k26_1406_1412 Raphael, 1991, Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors, Arch Pathol Lab Med, 115, 15 Burmeister, 2005, Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features, Leukemia, 19, 1391, 10.1038/sj.leu.2403847 Hecht, 2000, Molecular biology of Burkitt's lymphoma, J Clin Oncol, 18, 3707, 10.1200/JCO.2000.18.21.3707 Magrath, 1984, An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults, Blood, 63, 1102, 10.1182/blood.V63.5.1102.1102 Hummel, 2006, A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling, N Engl J Med, 354, 2419, 10.1056/NEJMoa055351 Dogan, 2000, CD10 and bcl-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas, Am J Surg Pathol, 24, 846, 10.1097/00000478-200006000-00010 Rodig, 2008, Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation, Am J Surg Pathol, 32, 113, 10.1097/PAS.0b013e3180959e09 Chuang, 2007, Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH, Am J Clin Pathol, 128, 558, 10.1309/EQJR3D3V0CCQGP04 Lim, 2005, Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy, J Clin Oncol, 23, 8477, 10.1200/JCO.2005.02.9355 Rochford, 2005, Endemic Burkitt's lymphoma: a polymicrobial disease?, Nat Rev Microbiol, 3, 182, 10.1038/nrmicro1089 Robbiani, 2008, AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations, Cell, 135, 1028, 10.1016/j.cell.2008.09.062 Bellan, 2005, Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas, Blood, 106, 1031, 10.1182/blood-2005-01-0168 Shiramizu, 1991, Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association, Blood, 77, 1516, 10.1182/blood.V77.7.1516.1516 Boerma, 2009, Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of today's knowledge, Leukemia, 23, 225, 10.1038/leu.2008.281 Gaidano, 1995, Molecular pathogenesis of AIDS-related lymphomas, Adv Cancer Res, 67, 113, 10.1016/S0065-230X(08)60712-5 Leucci, 2008, MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation, J Pathol, 216, 440, 10.1002/path.2410 Dave, 2006, Molecular diagnosis of Burkitt's lymphoma, N Engl J Med, 354, 2431, 10.1056/NEJMoa055759 Blum, 2004, Adult Burkitt leukemia and lymphoma, Blood, 104, 3009, 10.1182/blood-2004-02-0405 Nomura, 2008, High-grade mature B-cell lymphoma with Burkitt-like morphology: results of a clinicopathological study of 72 Japanese patients, Cancer Sci, 99, 246, 10.1111/j.1349-7006.2007.00681.x Magrath, 1996, Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen, J Clin Oncol, 14, 925, 10.1200/JCO.1996.14.3.925 Mead, 2002, An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study, Ann Oncol, 13, 1264, 10.1093/annonc/mdf253 Divine, 2005, Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol, Ann Oncol, 16, 1928, 10.1093/annonc/mdi403 Cairo, 2003, Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience, Br J Haematol, 120, 660, 10.1046/j.1365-2141.2003.04134.x Soussain, 1995, Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols, Blood, 85, 664, 10.1182/blood.V85.3.664.bloodjournal853664 Patte, 2007, Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients, Blood, 109, 2773, 10.1182/blood-2006-07-036673 Haralambieva, 2005, Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma, Am J Surg Pathol, 29, 1086, 10.1097/01.pas.0000168176.71405.e5 McClure, 2005, Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior, Am J Surg Pathol, 29, 1652, 10.1097/01.pas.0000180442.87022.08 Le Gouill, 2007, The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement, Haematologica, 92, 1335, 10.3324/haematol.11305 Kanungo, 2006, Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis, Mod Pathol, 19, 25, 10.1038/modpathol.3800500 van Imhoff, 2006, Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma, J Clin Oncol, 24, 4135, 10.1200/JCO.2006.05.5897 Leoncini, 2005, Aggressive B-cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology, Histopathology, 46, 241, 10.1111/j.1365-2559.2005.02068.x Knezevich, 2005, Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas, Leukemia, 19, 659, 10.1038/sj.leu.2403661 Macpherson, 1999, Small noncleaved, non-Burkitt's (Burkitt-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation, J Clin Oncol, 17, 1558, 10.1200/JCO.1999.17.5.1558